Market Cap 157.65B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 9.07
Forward PE 9.29
Profit Margin 12.42%
Debt to Equity Ratio 0.74
Volume 28,776,600
Avg Vol 37,498,578
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 52%
Beta 0.34
Analysts Sell
Price Target $28.92

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
HoneyButter
HoneyButter Sep. 22 at 2:25 PM
$VKTX the real play here is as an acquisition target. $MRK or $PFE are the most likely. For a mere $7-10 billion they get a drug that has best in class weight loss, orally available, well tolerated, weight loss is immediate out the gate, and transitions to monthly maintenance. Whomever acquires this company is immediately in the game.
2 · Reply
PAHANA
PAHANA Sep. 22 at 2:16 PM
$PFE Revenue is down 2% YoY while $NVO revenue is up 6% YoY yeah stupid
0 · Reply
focafoca99
focafoca99 Sep. 22 at 2:15 PM
$PFE opens webcast registration for its November 3 analyst call. https://www.rapidticker.com/news/pfe-pfizer-invites-public-to-view-f60b9c
0 · Reply
La_Parka3
La_Parka3 Sep. 22 at 2:01 PM
$MRNA $PFE Again, don’t say I didn’t warn the shorts that the Illuminati, the Freemasons, the Rothschilds, the World Economic Forum, and the New World Order have an agenda, and they have the longs’ backs. 🤣🤣🤣 I posted this a week ago. More pain to come for the shorts. And a big thank you to all the groups above for taking such good care of my investment.
0 · Reply
mrtallman
mrtallman Sep. 22 at 1:44 PM
$PFE ticker FLNA will double today. Drug study resumed
0 · Reply
DefenseMania
DefenseMania Sep. 22 at 1:15 PM
$AMGN $LLY $PFE $ABBV https://finance.yahoo.com/healthcare/articles/amgen-announces-positive-topline-phase-130000414.html
0 · Reply
biolover
biolover Sep. 22 at 1:12 PM
0 · Reply
UnKnownWall
UnKnownWall Sep. 22 at 12:57 PM
$VKTX $VKTX maintenance trial, 98% kept their loss-weight on every other week, 90% kept their loss-weight on monthly dose !!! $LLY $NVO $PFE $MRK and big pharms now time to offer your price. Expect the news of offering and tomorrow BL Forum. Brian has to say nice words
0 · Reply
TopShelfStock
TopShelfStock Sep. 22 at 12:51 PM
$NVAX $NVAX The opening bell is ringing here at 8:30 AM Central Time and the setup is looking PHENOMENAL. 🔔🔥 Don't lose sight of the big picture today. Novavax is completely evolving into a high-margin biotech powerhouse. The chart is screaming bullish, holding beautifully above the 20-day and 50-day EMAs on surging volume. 📈 Smart money is laser-focused on two massive, game-changing fundamental catalysts right around the corner: The Pfizer Factor: $PFE has locked in their disease target. The second clinical trials are officially initiated, a massive $70M cash milestone is unlocked. 💰 The Oncology Revolution: Preclinical data drop expected in the coming quarters showing Matrix-M turning "cold" tumors "hot" to shrink them. 🔬 The platform pivot is real, the revenue runway is secured into the 2030s, and the tape is ready to squeeze.Let's smash through resistance today, bulls. Hold tight! 💎🙌🚀 #OpeningBell #BioTech #Breakout
1 · Reply
biolover
biolover Sep. 22 at 12:43 PM
$VKTX That is $PFE $10 B drug performance at wk 28 wt loss (12% despite wkly doses and flattening of curve vs 22% at $VKTX 33 wks ) and look at vomit rate in the monthly maintenance in vesper 1 after wk 28
0 · Reply
Latest News on PFE
Pfizer Transcript: U.S. All Stars Conference

Sep 22, 2026, 6:50 AM EDT - 3 hours ago

Pfizer Transcript: U.S. All Stars Conference


Trump administration to announce drug pricing deals

Aug 31, 2026, 12:09 PM EDT - 21 days ago

Trump administration to announce drug pricing deals

AMGN LLY PFE TAK


Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Earnings Call Transcript: Q2 2026


Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Earnings release: Q2 2026


Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Slides: Q2 2026


Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Quarterly report: Q2 2026


Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 7 weeks ago

Pfizer Post Loss on Higher Revenue

PFE


Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 2 months ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

PFE


Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 2 months ago

Pfizer Declares Third-Quarter 2026 Dividend

PFE


Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit

PFE


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 3 months ago

Pfizer CFO Dave Denton to step down, leave company in August

PFE


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 3 months ago

Pfizer Announces Chief Financial Officer Transition

PFE


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 3 months ago

US FDA approves Pfizer's bleeding disorder drug for children

PFE


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Slides: Study update


Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Press release: Study update


HoneyButter
HoneyButter Sep. 22 at 2:25 PM
$VKTX the real play here is as an acquisition target. $MRK or $PFE are the most likely. For a mere $7-10 billion they get a drug that has best in class weight loss, orally available, well tolerated, weight loss is immediate out the gate, and transitions to monthly maintenance. Whomever acquires this company is immediately in the game.
2 · Reply
PAHANA
PAHANA Sep. 22 at 2:16 PM
$PFE Revenue is down 2% YoY while $NVO revenue is up 6% YoY yeah stupid
0 · Reply
focafoca99
focafoca99 Sep. 22 at 2:15 PM
$PFE opens webcast registration for its November 3 analyst call. https://www.rapidticker.com/news/pfe-pfizer-invites-public-to-view-f60b9c
0 · Reply
La_Parka3
La_Parka3 Sep. 22 at 2:01 PM
$MRNA $PFE Again, don’t say I didn’t warn the shorts that the Illuminati, the Freemasons, the Rothschilds, the World Economic Forum, and the New World Order have an agenda, and they have the longs’ backs. 🤣🤣🤣 I posted this a week ago. More pain to come for the shorts. And a big thank you to all the groups above for taking such good care of my investment.
0 · Reply
mrtallman
mrtallman Sep. 22 at 1:44 PM
$PFE ticker FLNA will double today. Drug study resumed
0 · Reply
DefenseMania
DefenseMania Sep. 22 at 1:15 PM
$AMGN $LLY $PFE $ABBV https://finance.yahoo.com/healthcare/articles/amgen-announces-positive-topline-phase-130000414.html
0 · Reply
biolover
biolover Sep. 22 at 1:12 PM
0 · Reply
UnKnownWall
UnKnownWall Sep. 22 at 12:57 PM
$VKTX $VKTX maintenance trial, 98% kept their loss-weight on every other week, 90% kept their loss-weight on monthly dose !!! $LLY $NVO $PFE $MRK and big pharms now time to offer your price. Expect the news of offering and tomorrow BL Forum. Brian has to say nice words
0 · Reply
TopShelfStock
TopShelfStock Sep. 22 at 12:51 PM
$NVAX $NVAX The opening bell is ringing here at 8:30 AM Central Time and the setup is looking PHENOMENAL. 🔔🔥 Don't lose sight of the big picture today. Novavax is completely evolving into a high-margin biotech powerhouse. The chart is screaming bullish, holding beautifully above the 20-day and 50-day EMAs on surging volume. 📈 Smart money is laser-focused on two massive, game-changing fundamental catalysts right around the corner: The Pfizer Factor: $PFE has locked in their disease target. The second clinical trials are officially initiated, a massive $70M cash milestone is unlocked. 💰 The Oncology Revolution: Preclinical data drop expected in the coming quarters showing Matrix-M turning "cold" tumors "hot" to shrink them. 🔬 The platform pivot is real, the revenue runway is secured into the 2030s, and the tape is ready to squeeze.Let's smash through resistance today, bulls. Hold tight! 💎🙌🚀 #OpeningBell #BioTech #Breakout
1 · Reply
biolover
biolover Sep. 22 at 12:43 PM
$VKTX That is $PFE $10 B drug performance at wk 28 wt loss (12% despite wkly doses and flattening of curve vs 22% at $VKTX 33 wks ) and look at vomit rate in the monthly maintenance in vesper 1 after wk 28
0 · Reply
TheUnmaker
TheUnmaker Sep. 22 at 12:40 PM
0 · Reply
TopShelfStock
TopShelfStock Sep. 22 at 12:26 PM
$NVAX Good morning, $NVAX bulls! ☀️ Let’s get after it today. Chart is looking beautiful as we trade strong above the 20-day and 50-day EMAs on rising volume. 📈 The technical breakout is aligning perfectly with the massive fundamental shift. Don't lose sight of what's ahead:🚀 $70M Pfizer Milestone: $PFE has chosen their target. The second clinical trials launch, that cash is triggered.🔬 Oncology Pivot: Game-changing data on Matrix-M shrinking tumors expected in the coming quarters. Shaking off the macro noise and moving toward a high-margin future. Have a great trading day, everyone! Let's squeeze higher. 💎🚀 #BioTech #Investing
0 · Reply
hardworking_student
hardworking_student Sep. 22 at 11:35 AM
$VKTX how soon does the bidding war start? $PFE should have just paid BL what he wanted, you get what you pay for
0 · Reply
Agent8
Agent8 Sep. 22 at 11:22 AM
$PFE U.S. All Stars Conference going on right now, pretty impressive! https://www.stocktwits.com/symbol/PFE/companycall
0 · Reply
taxplanr
taxplanr Sep. 22 at 11:06 AM
The whole world is walking away from COVID mRNA $BNTX $PFE $MRNA https://www.thefocalpoints.com/p/allison-inquiry-has-ripple-effect?r=14jb45&amp%3Butm_campaign=post-expanded-share&amp%3Butm_medium=web&triedRedirect=true
0 · Reply
taxplanr
taxplanr Sep. 22 at 4:01 AM
63 million people sign petition to POTUS to remove $MRNA $PFE $BNTX COVID vaccines from the market ... in an election year https://www.instagram.com/reel/DdkElz7POXS/?stkn=N2U0aDJxYTRjZjF0
1 · Reply
flowerchefstocks
flowerchefstocks Sep. 21 at 10:09 PM
$PFE Killer article on the ADC Market. Looks like the Seagen acquisition might get a chance to recoup some of the investment outlaid for the purchase of the ADC technology which to date has been a bust. But this CD228 target looks very interesting. https://www.streetwisereports.com/article/2026/09/21/medicuss-pfizer-deal-was-not-a-fire-sale-a-strategic-bet-on-de-risked-adc-drug.html
0 · Reply
zustrelaax
zustrelaax Sep. 21 at 9:45 PM
$PFE news?
1 · Reply
reyofhope
reyofhope Sep. 21 at 8:25 PM
$PFE I've been waiting 2 years for this shit to move if I had put my 50 k in AMD I would have been rich . I'm so pissed.
4 · Reply
Hero07
Hero07 Sep. 21 at 8:17 PM
$VKTX Someone on X says wsj or FT reporting bidding war with $NOVO.X $PFE coming in…it could get interesting, both must of seen the data
2 · Reply
zustrelaax
zustrelaax Sep. 21 at 6:47 PM
$PFE just run with the market
0 · Reply
INEEDMONEY87
INEEDMONEY87 Sep. 21 at 6:41 PM
0 · Reply